Herbert Virgin - 02 Nov 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: EVP, Research & CSO
Signature: /s/ Howard Horn, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 02 Nov 2021
Net transactions value: -$48,689
Form type: 4
Filing time: 03 Nov 2021, 16:33:01 UTC
Previous filing: 21 Oct 2021
Next filing: 18 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$2,104	+1,375	+1.3%	$1.53^*	109,075	02 Nov 2021	Direct
transaction	VIR	Common Stock	Sale	$50,792	-1,375	-1.3%	$36.94	107,700	02 Nov 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-1,375	-0.55%	$0.000000	247,005	02 Nov 2021	Common Stock	1,375	$1.53	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
F2	1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.